35 / 88
35
Monday, 19 June 2017
/ Scientific Programme
WFSBP 2017
MON
T32: PHARMACOGENETICS
TFW-01
WFSBP TASK FORCE WORKSHOP
15:00–16:30
Auditorium 12
Workshop of the WFSBP Task Force on genetics: Focus
on pharmacogenomics
Chair:
Dan Rujescu, Germany
Co-Chair: Jim Kennedy, Canada
001
Pharmacogenetics in schizophrenia
Rainald Mössner, Germany
002
Largest genome wide association study on
agranulocytosis under Clozapine
Dan Rujescu, Germany
003
Whole exom sequencing reveals risk factors in
treatment resistant depression
Alessandro Serretti, Italy
004
Pharmacogenetic discoveries and applications in
psychiatric populations
Jim Kennedy, Canada
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-25
SYMPOSIUM
15:00–16:30
Auditorium 15
tDCS: From research to clinical practice
Chair:
Jerome Brunelin, France
001
Translational research on tDCS: Data from a
German multisite project
Frank Padberg, Germany
002
Combining tDCS with neuroimaging
Shirley Fecteau, Canada
003
Effects of tDCS on biological reactivity to stress
and decision making
Jerome Brunelin, France
004
Improvement of cognitive control with anodal
tDCS: Translational perspectives for the treatment of
depression
Christian Plewnia, Germany
T33: PHARMACOLOGY
S-26
SYMPOSIUM
15:00–16:30
Auditorium 10
Into novel drugs for depression
Chair:
Erich Seifritz, Switzerland
001
Conceptual strategies of Big Pharma into innova-
tion in psychiatric therapies: Future leads
Siegfried Kasper, Austria
002
Personalizing psychiatry treatment
Florian Holsboer, Germany
003
Psychedelic drugs and clinical markers as innova-
tion road to psychopharmacotherapy
Katrin Preller, Switzerland
004
Gamma-hydroxybutyrate: neuropharmacology and
implications for depression treatment
Oliver G. Bosch, Switzerland
T43: SCHIZOPHRENIA: BASIC/ CLINICAL
S-27
SYMPOSIUM
15:00–16:30
Auditorium 11
Beyond unitary models of psychosis: Confronting
complex etiology and dimensionality
Chair:
Mikhail Pletnikov, USA
Co-Chair: John Waddington, Ireland
001
Recognising the dimensionality of psychotic ill-
ness: Broadening the phenotype to the affective domain
Catherine Belzung, France
002
Addressing the translational challenge of etiolo-
gical diversity: Complex gene-environment interactions
in risk for psychosis
Mikhail Pletnikov, USA
003
Closing the translational gap between heritability
and genetics: Complex gene-gene interactions in risk
for psychosis
John Waddington, Ireland
004
Extending the strategy for translation: Human
induced pluripotent stem cells
Kristen Brennand, USA
T11: DEPRESSION: BASIC/ CLINICAL
S-28
SYMPOSIUM
15:00–16:30
B3 M3-M4
Wake and sleep electroencephalogramm provide
biomarkers of depression
Chair:
Axel Steiger, Germany
Co-Chair: Thorsten Mikoteit, Switzerland
001
Central and autonomous nervous system activity
in the prediction of antidepressant treatment
Sebastian Olbrich, Switzerland
002
The value of prefrontal theta cordance of resting
EEG in the prediction of antidepressant response
Martin Brunovsky, Czech Republic
003
Novel REM-sleep derived biomarkers of depression
Thorsten Mikoteit, Switzerland